May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
N–(4–hydroxylphenyl)retinamide Induces Apoptosis In Retinoblastoma Cell Lines
Author Affiliations & Notes
  • D.D. Chism
    Department of Ophthalmology, Univ. of TN College of Medicine, Memphis, TN
    Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN
  • N.A. Laurie
    Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN
  • M.W. Wilson
    Department of Ophthalmology, Univ. of TN College of Medicine, Memphis, TN
  • M.A. Dyer
    Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN
  • Footnotes
    Commercial Relationships  D.D. Chism, None; N.A. Laurie, None; M.W. Wilson, None; M.A. Dyer, None.
  • Footnotes
    Support  NIH, NCI, Pew Scholars RPB and USPHS Grant T35 DK07405
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 2817. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D.D. Chism, N.A. Laurie, M.W. Wilson, M.A. Dyer; N–(4–hydroxylphenyl)retinamide Induces Apoptosis In Retinoblastoma Cell Lines . Invest. Ophthalmol. Vis. Sci. 2006;47(13):2817.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Effective chemotherapies with minimal acute and delayed toxicities are needed for the treatment of retinoblastoma. N–(4–hydroxylphenyl)retinamide, (4–HPR or fenretinide), a synthetic derivative of all–trans–retinoic acid (ATRA) has been found to induce apoptosis in ATRA–resistant cell lines. The objective of this study was to examine its effects in Y79 and Weri1 retinoblastoma cell lines.

Methods: : Human retinoblastoma cell lines (Weri1 and Y79) were treated with varying concentrations of 4HPR (1nM–100 µM) in vitro. We utilized flow cytometry assays to determine the effect of 4HPR on cell viability, proliferation, apoptosis, and cell cycle arrest.

Results: : Cells treated with 4–HPR showed a dose–and time–dependent induction of apoptosis. The LC50 for 4–HPR in Y79 and Weri1 cells were 3.2 µM and 6.1 µM respectively. Cell cycle studies demonstrated an S phase accumulation when cells were exposed to high concentrations of 4–HPR (> LC50 ) compared to the ethanol–treated control. A sub–G1 fraction consistent with apoptosis was also detected.

Conclusions: : The ability of 4–HPR to induce apoptosis in retinoblastoma cell lines suggests that it could be a promising therapeutic treatment for this disease.

Keywords: retinoblastoma • clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials • tumors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×